AMICUS THERAPEUTICS INC COM STK USD0.01AMICUS THERAPEUTICS INC COM STK USD0.01AMICUS THERAPEUTICS INC COM STK USD0.01

AMICUS THERAPEUTICS INC COM STK USD0.01

No trades
See on Supercharts

0HF9 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

0HF9 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company